Valve Medical’s Xemed TAVR System Used in First-in-Human Implantation in Israel
May 31, 2023—Valve Medical, a wholly owned subsidiary of Medinol Ltd., announced the successful first-in-human implantation of the company’s Xemed transcatheter aortic valve replacement (TAVR) system, which features a modular valve.
